A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within the cells.

The team stained a library of cells with fluorescently labelled antibodies for each target protein alongside markers for notable structures, such as the nucleus and mitochondria. These cellular ...

Methyl eugenol (ME) possesses significant antioxidant, anticancer and neuroprotective properties, potentially beneficial ...

Visakhapatnam: A group of researchers at Andhra University have recently obtained a patent for a portable biosensor designed ...

Assistant Professor Katherine Alexander and University of Pennsylvania Professor Shelley Berger have found a possible source of this variability in clear cell renal cell carcinoma (ccRCC)—the ...

Methyl eugenol (ME), a phenylpropanoid compound found in the essential oils of various aromatic plants, has recently garnered attention due to its ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announces the publication of ...

Neurosurgery experts from UCSF Health will present new research and clinical findings at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Boston, April 25-28.

and his team of researchers have devised an effective means to grow iPS cell-derived kidney progenitor cells, paving the way for renal regenerative therapies to become a reality. The findings are ...

Current evidence shows limited benefit from additional immunotherapy in renal cell carcinoma patients previously treated with immune checkpoint inhibitors. Two large randomized trials yielded negative ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...